Fonar Corp.
FONR | NASDAQ
$19.09
$0 (0.00%)
Jun 5, 2026, 4:00 PM ET · Market open
Company Profile
FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates through two segments, Medical Equipment segment, and Physician Management and Diagnostic services segment. It provides Upright MRI scanner that allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. The company offers non-medical management, including administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting, assistance with compliance matters and the development and implementation of practice growth and marketing strategies. The company owns and operates 5 diagnostic imaging facilities in Florida; and manages 39 MRI scanning facilities, including 25 facilities located in New York and 14 situated in Florida. It markets its scanners to private diagnostic imaging centers and hospitals. The company was incorporated in 1978 and is based in Melville, New York.
Key Executives
| Name | Position |
|---|---|
| Timothy R. Damadian | Chairman, President, Chief Executive Officer & Treasurer |
| Luciano Bonanni | Chief Operating Officer, Executive Vice President & Acting Principal Financial Officer |
| Daniel Culver | Director of Communications |
| John Collins | General Counsel & Acting Secretary |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jun 04, 2026 | 4 | Filing |
| Jun 03, 2026 | SC 13D/A | [Amend] Filing |
| Jun 03, 2026 | 25-NSE | Filing |
| May 29, 2026 | 4 | Filing |
| May 29, 2026 | 8-K | Current Report |
| May 27, 2026 | 4 | Filing |
| May 26, 2026 | 3 | Filing |
| May 21, 2026 | DEFA14A | Filing |
| May 21, 2026 | 8-K | Current Report |
| May 14, 2026 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
Fonar Corp.
| Country | United States |
| IPO Date | Oct 28, 1981 |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Employees | 520 |
| CEO | Timothy R. Damadian |
Contact Details
110 Marcus Drive Melville,
New York 11747 United States
Stock Details
| Ticker Symbol | FONR |
| Exchange | NASDAQ |
| Fiscal Year | July - June |
| Reporting Currency | USD |
| CIK Code | 0000355019 |
| CUSIP Number | 344437405 |
| ISIN Number | US3444374058 |
| SIC Code | 3845 |
Add to Watchlist
Select watchlists to add or remove FONR